Pharmerica Stock Hits New 52-Week Low (PMC)

NEW YORK ( TheStreet) -- Pharmerica Corporation (NYSE: PMC) hit a new 52-week low Thursday as it is currently trading at $9.88, below its previous 52-week low of $9.98 with 33,328 shares traded as of 10:55 a.m. ET. Average volume has been 308,200 shares over the past 30 days.

Pharmerica has a market cap of $300.6 million and is part of the services sector and retail industry. Shares are down 33.9% year to date as of the close of trading on Wednesday.

Pharmerica Corporation operates as an institutional pharmacy services company in the United States. It offers services to healthcare facilities and provides management pharmacy services to hospitals. The company has a P/E ratio of 11.7, equal to the average retail industry P/E ratio and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Pharmerica as a hold. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and poor profit margins. You can view the full Pharmerica Ratings Report.

See all 52-week low stocks or get investment ideas from our investment research center.
null

If you liked this article you might like

Private Briefing: KKR's Healthcare Deal Spree

Private Briefing: KKR's Healthcare Deal Spree

Walgreens Takes Piece of PharMerica, Quest to Dominate Healthcare Continues

Walgreens Takes Piece of PharMerica, Quest to Dominate Healthcare Continues

Magellan Shares Up Strong After Shelling Out $400M to Buy Senior Whole Health

Magellan Shares Up Strong After Shelling Out $400M to Buy Senior Whole Health

13 Things Kentucky Is Best Known for Other Than the Kentucky Derby

13 Things Kentucky Is Best Known for Other Than the Kentucky Derby

PharMerica (PMC) Stock Soars, Exploring Possible Sale

PharMerica (PMC) Stock Soars, Exploring Possible Sale